Palvella Therapeutics develops topical drug candidates for rare skin diseases and vascular malformations, aimed at patients and their doctors. It last closed at $142.85 on Nov 20, down 2.00% on the day. The next earnings report for PVLA is expected around Tue, Feb 23, 2027, after the close. For the quarter ended Sep 2026, PVLA reported EPS of -$1.70. Over its last 8 reports the stock moved an average of 6.3% the session after earnings. Over the last 12 months PVLA insiders bought $850K of stock on the open market and sold $15.6M, according to SEC Form 4 filings.
AI Auto Pilots
Is PVLA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PVLA.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on PVLAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
PVLA · as of the Nov 20 close · updated each morning
Moving sideways
The stock sits between its 20 and 50 day averages. It is 8% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 46). The nearest support is the 50 day average at $142.81, and the nearest resistance the Pivot at $144.59.
Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 6.2%/day
Key levels
$179.9552 week high+26.0%
$152.80Swing high (Jul 9)+7.0%
$151.7620 day average+6.2%
$146.95Pivot R1+2.9%
$145.70100 day average+2.0%
$144.59Pivot+1.2%
$142.85Last close
$142.8150 day average−0.0%
$140.54Swing low (Nov 17)−1.6%
$140.48Pivot S1−1.7%
$132.09200 day average−7.5%
$72.2252 week low−49.4%
Indicators
RSI (14)
45.89
Middle of its range
Neutral
MACD
1.84
Below its signal line
Bearish
Stochastic
11.5
Near the bottom of its range
Oversold
ADX (14)
22.0
Weak trend
Williams %R
-94.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-48.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−18.8%
Change over 10 sessions
Bearish
ATR (14)
$8.87
Typical daily range, 6.2% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Below
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 14.0%/day
Key levels
$179.9552 week high+26.0%
$152.80Swing high (Jul 9)+7.0%
$151.7620 day average+6.2%
$146.95Pivot R1+2.9%
$145.70100 day average+2.0%
$144.59Pivot+1.2%
$142.85Last close
$142.8150 day average−0.0%
$140.54Swing low (Nov 17)−1.6%
$140.48Pivot S1−1.7%
$132.09200 day average−7.5%
$72.2252 week low−49.4%
Indicators
RSI (14)
51.66
Middle of its range
Neutral
MACD
6.44
Below its signal line
Bearish
Stochastic
64.5
Middle of its range
Neutral
ADX (14)
20.0
No clear trend
Williams %R
-60.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
9.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−4.8%
Change over 10 sessions
Bearish
ATR (14)
$19.98
Typical daily range, 14.0% of price
MA 10Above
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for PVLA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PVLA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow PVLA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for PVLAHow many large options trades hit PVLA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in PVLA in the last 90 days.
From SEC Form 4 filings by PVLA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PVLA is in one of them and how their past PVLA trades turned out.
Palvella Therapeutics is a biopharmaceutical company based in Wayne, Pennsylvania, that is developing topical treatments for rare skin diseases and vascular malformations where no approved therapies exist. Its lead candidate, a rapamycin gel called QTORIN rapamycin, is in clinical trials for microcystic lymphatic malformations and cutaneous venous malformations. The company also has a candidate in development for disseminated superficial actinic porokeratosis. Its target customers are patients with these conditions and the physicians who treat them.